Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk

Author(s): A. K. Burroughs, E. Xirouchakis, A. Sigalas, P. Manousou, V. Calvaruso, M. Pleguezuelo, A. Corbani, S. Maimone, D. Patch

Journal Name: Current Pharmaceutical Design

Volume 14 , Issue 4 , 2008

Become EABM
Become Reviewer


Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.

Keywords: Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, vascular risk

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [378 - 384]
Pages: 7
DOI: 10.2174/138161208783497705
Price: $65

Article Metrics

PDF: 3